Increased activity of the AHR- IDO1-TDO2 pathway in the tumor microenvironment is related to poor prognosis in Merkel cell carcinoma [29], which is consistent with the results of the present study. This evidence concerns the gene IDO1 and Merkel cell skin cancer.